These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. NT-proBNP levels in systemic sclerosis: association with clinical and laboratory abnormalities. Oravec RM; Bredemeier M; Laurino CC; Pinotti AF; Rohde LE; Brenol JC; Xavier RM Clin Biochem; 2010 Jun; 43(9):745-9. PubMed ID: 20350538 [TBL] [Abstract][Full Text] [Related]
45. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension. Bernstein EJ; Gordon JK; Spiera RF; Huang WT; Horn EM; Mandl LA Rheumatology (Oxford); 2017 Jan; 56(1):87-94. PubMed ID: 28028158 [TBL] [Abstract][Full Text] [Related]
47. [Pulmonary hypertension in rheumatic diseases]. Manganelli P; Salaffi F; Carotti M; Delsante G; Mozzani F Minerva Med; 1999 Mar; 90(3):59-72. PubMed ID: 10432956 [TBL] [Abstract][Full Text] [Related]
48. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Meune C; Avouac J; Airò P; Beretta L; Dieudé P; Wahbi K; Caramaschi P; Tiev K; Cappelli S; Diot E; Vacca A; Cracowski JL; Sibilia J; Kahan A; Matucci-Cerinic M; Allanore Y Arthritis Rheum; 2011 Sep; 63(9):2790-6. PubMed ID: 21547892 [TBL] [Abstract][Full Text] [Related]
49. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients. Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897 [TBL] [Abstract][Full Text] [Related]
50. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study. Gadre A; Ghattas C; Han X; Wang X; Minai O; Highland KB Lung; 2017 Oct; 195(5):529-536. PubMed ID: 28646245 [TBL] [Abstract][Full Text] [Related]
51. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Jimenez SA; Piera-Velazquez S Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760 [TBL] [Abstract][Full Text] [Related]
52. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Chung SM; Lee CK; Lee EY; Yoo B; Lee SD; Moon HB Clin Rheumatol; 2006 Nov; 25(6):866-72. PubMed ID: 16496078 [TBL] [Abstract][Full Text] [Related]